The underlying hypothesis is that an age-related accumulation of oxidative damage to mitochondria causes increasing mitochondrial dysfunction resulting in impaired Ca 2+ regulation, greater production of reactive oxygen species (Aim 1), and greater release of death-related proteins in response to insult (Aim 2). Calpains, Ca2+-activated cysteine proteases, are impacted by both Ca 2+ dysregulation and oxidative stress. Preliminary results suggest that m-calpain is associated with mitochondria, where its substrates may include many cell-death related proteins (Aim 3). Mitochondrial calpain would be ideally situated for regulation by mitochondrial Ca 2+ release and redox mechanisms, similar to the recently described mitochondrial nitric oxide synthase. The age-related alterations in mitochondrial function and cell death proteins are hypothesized to be exacerbated in vulnerable brain regions in AIzheimer's disease (AD), as compared to resistant brain regions and mitochondrial function in elderly individuals with less severe cognitive decline and neuropathology (Aim 4). However, increased oxidative stress in aging and AD may limit the activity of calpain and other cysteine proteases, possibly protecting against the consequences of Ca 2+ dysregulation but also limiting the proteolysis of substrate proteins (Aim 4). To examine the basic premise, that an age-related accumulation of oxidative damage to mitochondria results in their dysfunction, iwe will examine the efficacy of long-term anti-oxidant (lipoic acid) and NMDA receptor antagonism (memantine) intervention in attenuating the age-related alterations in mitochondrial function (Aim 5). The above studies of mitochondrial function will be performed on synaptic and non-synaptic mitochondrial fractions isolated from the cortex and cerebellum of rats of ages 1-24 months, and from human brain autopsy tissues obtained from individuals with various levels of cognitive function and AD-related europathology. The maximum postmortem interval is 5h. While many aspects of mitochondrial dysfunction have been examined in aging and AD, few studies have examined isolated mitochondria and even fewer have evaluated synaptic vs. non-synaptic mitochondria. Together, the studies outlined in this project will provide a comprehensive evaluation of mitochondrial function and dysfunction in aging and AD, and the relationship of mitochondrial dysfunction to the age-related Ca2+ deregulation and oxidative stress.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Program Projects (P01)
Project #
5P01AG010836-13
Application #
7274272
Study Section
Special Emphasis Panel (ZAG1)
Project Start
Project End
Budget Start
2006-09-01
Budget End
2007-08-31
Support Year
13
Fiscal Year
2006
Total Cost
$180,504
Indirect Cost
Name
University of Kentucky
Department
Type
DUNS #
939017877
City
Lexington
State
KY
Country
United States
Zip Code
40506
Butterfield, D Allan; Palmieri, Erika M; Castegna, Alessandra (2016) Clinical implications from proteomic studies in neurodegenerative diseases: lessons from mitochondrial proteins. Expert Rev Proteomics 13:259-74
Chen, Chun-Hau; Li, Wenzong; Sultana, Rukhsana et al. (2015) Pin1 cysteine-113 oxidation inhibits its catalytic activity and cellular function in Alzheimer's disease. Neurobiol Dis 76:13-23
Barone, Eugenio; Di Domenico, Fabio; Butterfield, D Allan (2014) Statins more than cholesterol lowering agents in Alzheimer disease: their pleiotropic functions as potential therapeutic targets. Biochem Pharmacol 88:605-16
Cenini, Giovanna; Fiorini, Ada; Sultana, Rukhsana et al. (2014) An investigation of the molecular mechanisms engaged before and after the development of Alzheimer disease neuropathology in Down syndrome: a proteomics approach. Free Radic Biol Med 76:89-95
Barone, Eugenio; Di Domenico, Fabio; Mancuso, Cesare et al. (2014) The Janus face of the heme oxygenase/biliverdin reductase system in Alzheimer disease: it's time for reconciliation. Neurobiol Dis 62:144-59
Förster, Sarah; Welleford, Andrew S; Triplett, Judy C et al. (2014) Increased O-GlcNAc levels correlate with decreased O-GlcNAcase levels in Alzheimer disease brain. Biochim Biophys Acta 1842:1333-9
Swomley, Aaron M; Förster, Sarah; Keeney, Jierel T et al. (2014) Abeta, oxidative stress in Alzheimer disease: evidence based on proteomics studies. Biochim Biophys Acta 1842:1248-57
Latimer, Caitlin S; Brewer, Lawrence D; Searcy, James L et al. (2014) Vitamin D prevents cognitive decline and enhances hippocampal synaptic function in aging rats. Proc Natl Acad Sci U S A 111:E4359-66
Butterfield, D Allan; Di Domenico, Fabio; Barone, Eugenio (2014) Elevated risk of type 2 diabetes for development of Alzheimer disease: a key role for oxidative stress in brain. Biochim Biophys Acta 1842:1693-706
Perluigi, Marzia; Di Domenico, Fabio; Buttterfield, D Allan (2014) Unraveling the complexity of neurodegeneration in brains of subjects with Down syndrome: insights from proteomics. Proteomics Clin Appl 8:73-85

Showing the most recent 10 out of 356 publications